Bronchodilator Reversibility Occurring during the Acute Phase of Paragonimiasis westermani Infection
Autor: | Kosuke Yamaguchi, Eiji Shimizu, Tomoya Harada, Akira Yamasaki, Yuji Kawasaki, Hiroki Takami, Jun Kurai, Yoichi Osawa, Akira Tsukada |
---|---|
Rok vydání: | 2019 |
Předmět: |
medicine.medical_specialty
medicine.drug_class Pleural effusion business.industry Hypereosinophilia General Medicine medicine.disease Gastroenterology Pulmonary function testing Praziquantel hemic and lymphatic diseases Internal medicine Bronchodilator parasitic diseases Internal Medicine medicine Eosinophilia medicine.symptom business medicine.drug Asthma Paragonimiasis |
Zdroj: | Internal Medicine. 58:297-300 |
ISSN: | 1349-7235 0918-2918 |
DOI: | 10.2169/internalmedicine.0401-17 |
Popis: | A 43-year-old woman was referred to our hospital with peripheral blood hypereosinophilia and abnormal chest X-ray findings. Her pleural effusion revealed hypereosinophilia and a low glucose level. She was diagnosed with pulmonary paragonimiasis based on an elevated antibody level of Paragonimiasis westermani. Although she had no medical history of allergic disorders, a pulmonary function test revealed bronchodilator reversibility. After praziquantel therapy, her symptoms, hypereosinophilia in peripheral blood, and pleural effusion were improved. A repeated pulmonary function test after praziquantel therapy showed a negative bronchodilator response. Pulmonary paragonimiasis may induce bronchodilator reversibility during the acute phase of infection. |
Databáze: | OpenAIRE |
Externí odkaz: |